Decoy Therapeutics

Decoy Therapeutics, founded with a mission to enhance pandemic preparedness, is a preclinical stage biotech company leveraging AI to design peptide 'decoys' that disrupt viral replication. The company's vision is to create a robust platform for developing drugs that can be rapidly deployed in response to emerging viral threats. Decoy Therapeutics focuses on utilizing advanced computational methods to innovate therapeutic solutions, primarily targeting the global healthcare market.

Notable figures affiliated with Decoy Therapeutics include experts in biotechnology and AI-driven drug development, though specific names are not provided. The company operates from strategic locations in Cambridge, MA, and New York City. Key achievements include the development of their proprietary AI platform for peptide design, positioning them as a forward-thinking player in pandemic preparedness. Their impact lies in pioneering a new approach to antiviral drug development, potentially transforming how the world responds to future pandemics.